SEC Form 4 · accession 0001041889-16-000031
PSYCHEMEDICS CORP · PMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Harry F Connick Sr.
Director
Period of report
Feb 19, 2016
Accepted (ET)
Feb 23, 2016 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806517
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.005 Par ValueF1 | Feb 19, 2016 | P | 1,000 | $11.95 | D | 37,662 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.94 to $11.99, inclusive. The reporting person undertakes to provide to Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.